Accure Therapeutics
PrivateLast Round
Grant
Apr 7, 2025
Total Funding Raised
$9.7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Accure Therapeutics is a biotechnology company that develops a portfolio of new drug candidates to treat Central Nervous System (CNS) diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Accure Therapeutics Comparables
Compare Accure Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nura Bio | 80% | |
| Addex Therapeutics | 79% | |
| Find Therapeutics | 79% |
Accure Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 7, 2025 | ||||
| Series A | May 26, 2020 |
Accure Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Asabys Partners | Series A |
| Alta Life Sciences | Series A |
| Luxembourg National Research Fund | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| University of Barcelona | Grant, Series A |
| Center for Technological Development and Innovation | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 140% MoM, reaching 4K.
- Apr 15, 2026
Monthly visitors grew 44% MoM.
Accure Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Accure Therapeutics's valuation, stock price, and market status.
Is Accure Therapeutics a public or private company?
Accure Therapeutics is a private company.
What is the current stock price of Accure Therapeutics?
Accure Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Accure Therapeutics worth (valuation)?
Valuation information for Accure Therapeutics is not publicly available.
Can I buy Accure Therapeutics stock?
Accure Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Accure Therapeutics's last funding round?
Accure Therapeutics's most recent funding round was Grant on April 7, 2025.
Who are the main investors in Accure Therapeutics?
Key investors in Accure Therapeutics include Alta Life Sciences.
Will Accure Therapeutics IPO soon?
No public IPO plans have been announced for Accure Therapeutics.
How can I track Accure Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Accure Therapeutics's secondary market activity and sign up for updates.